The SULF2 (Sulfatase 2) antibody is a research tool used to detect and study the SULF2 protein, an extracellular sulfatase involved in modulating heparan sulfate proteoglycans (HSPGs). SULF2 regulates cell signaling by removing 6-O-sulfate groups from HSPGs, altering their interactions with growth factors, cytokines, and receptors. This enzyme plays critical roles in development, tissue homeostasis, and disease processes, particularly cancer. Dysregulated SULF2 expression has been linked to tumor progression, angiogenesis, and metastasis in hepatocellular carcinoma, pancreatic cancer, and glioblastoma.
SULF2 antibodies are typically monoclonal or polyclonal, developed for applications like Western blotting, immunohistochemistry, and immunofluorescence. They help researchers investigate SULF2's localization, expression patterns, and functional roles in pathological contexts. Recent studies highlight SULF2's dual role as both a tumor promoter and suppressor, depending on cellular context and microenvironment. Its involvement in Wnt, FGF, and BMP signaling pathways makes it a potential therapeutic target. However, challenges remain in understanding isoform-specific functions and post-translational modifications. Validated SULF2 antibodies are crucial for elucidating its mechanistic contributions to diseases and evaluating its utility as a diagnostic biomarker or therapeutic candidate. Ongoing research continues to explore its interplay with the extracellular matrix and implications for targeted therapies.